Jeffrey Litt

Jeffrey Litt, Ph.D., serves as a Senior Manager in Preclinical Development at Pulse Biosciences, Inc. since March 2020, leading in vivo pre-clinical medical device safety and efficacy testing. Previously, Jeffrey worked as a Scientist II at Verseon from July 2016 to July 2021, where responsibilities included leading an in vivo research team and supervising pharmacokinetics and toxicology studies. At UC Berkeley, Jeffrey was a Postdoctoral Research Assistant from August 2011 to June 2016, managing a team focused on restoring visual responses in blind mice and conducting advanced microscopy research. Jeffrey completed a Ph.D. in Chemical and Biological Engineering at Rensselaer Polytechnic Institute, where research included targeting amyloid beta aggregates related to Alzheimer’s disease.